Product Program year 2025 Source: CMS Open Payments

Elekta Unity

Device Linac Solutions (Mr-Linac)

PDI 05060191071598

Open in the dashboard

General payments

$244,953

446 payments

Research payments

$1,083,088

27 payments

Through program year 2025, $244,953 in general payments and $1,083,088 in research payments were reported against Elekta Unity (Linac Solutions (Mr-Linac)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $30,086 99
2025 Research $245,286 4
2024 General $2,916 31
2023 General $71,059 102
2023 Research $837,802 23
2022 General $62,738 123
2021 General $78,152 91

Breakdown

Who paid General payments · program years 2021–2025
  1. Elekta, Inc. $111,190 420 payments
  2. Elekta Limited $111,146 8 payments
  3. Elekta K.K. $20,740 12 payments
  4. Elekta Pte. Ltd $1,500 1 payment
  5. Elekta LTD $193 1 payment
  6. ELEKTA AB (publ) $134 3 payments
  7. Elekta Pty Ltd $50 1 payment
Top recipients General payments · program year 2025
  1. Christopher Crane Therapeutic Radiology · New York, NY $19,240 64% · 11 payments
  2. Himanshu Nagar Radiation Oncology · New York, NY $1,585 5% · 2 payments
  3. Chad Tang Radiation Oncology · Houston, TX $1,512 5% · 2 payments
  4. Michael Zelefsky Radiation Oncology · New York, NY $1,500 5% · 1 payment
  5. Joshua Niska Radiation Oncology · Phoenix, AZ $447 1% · 7 payments

The top 5 of 51 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Therapeutic Radiology Radiology $19,240 64% · 1 practitioner
  2. Radiation Oncology Radiology $10,561 35% · 46 practitioners
  3. Pediatrics $143 <1% · 1 practitioner
  4. General Practice $66 <1% · 1 practitioner
  5. Vascular Surgery Surgery $38 <1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. New York $22,324 74% · 3 recipients
  2. Arizona $1,806 6% · 9 recipients
  3. Texas $1,683 6% · 4 recipients
  4. California $1,188 4% · 9 recipients
  5. Oregon $1,131 4% · 4 recipients

The top 5 of 15 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

446 general · 27 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record